Joi Frontier

New Policies Could Lower Cost of Esketamine for Depression

Exciting changes might make a fast-acting depression treatment more accessible.

Mental Health Research·Source: MedicalXpress Psychiatry··1 min read
New Policies Could Lower Cost of Esketamine for Depression
New Policies Could Lower Cost of Esketamine for Depression

The short version

  • What they foundNew policies may reduce the cost of esketamine.
  • What it meansMore people could access this rapid treatment option.
  • What we don't know yetTiming and implementation of these policies are still unknown.

Researchers found that specific policy changes in Hong Kong could make esketamine nasal spray more affordable. Esketamine is a newer treatment option for adults with treatment-resistant depression (TRD), meaning it helps people who haven’t found relief from standard depression treatments. Together with other service improvements, these policies aim to increase accessibility and lower costs for patients in need.

Why it matters

Many people struggle with treatment-resistant depression. Making effective treatments like esketamine more affordable is crucial for those seeking help.

What to keep in mind

These changes are still in the planning stages. It’s not clear yet when they will take effect.

Read the originalThis is a Joi Frontier Health News summary. Read the full story at the original source: MedicalXpress Psychiatry.
Feeling something stir?Take the next small step in the JoiApp.
Continue with JoiApp

Joi Frontier Health News shares hopeful, credible health information. It is not medical advice, diagnosis, or treatment — talk with a qualified healthcare professional about your situation. If you are in crisis or thinking about self-harm, contact your local emergency or crisis line.

Comments

Comments here come from JoiApp readers.

Open in JoiApp to join the conversation

    Related